
Scott A. Browne
Examiner (ID: 11727, Phone: (571)270-0151 , Office: P/3617 )
| Most Active Art Unit | 3617 |
| Art Unit(s) | 3666, 4128, 3615, 3617 |
| Total Applications | 544 |
| Issued Applications | 383 |
| Pending Applications | 20 |
| Abandoned Applications | 143 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4824914
[patent_doc_number] => 20080124319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Methods for treating inflammation by disrupting MCH-mediated signaling'
[patent_app_type] => utility
[patent_app_number] => 11/804013
[patent_app_country] => US
[patent_app_date] => 2007-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6997
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11804013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/804013 | Methods for treating inflammation by disrupting MCH-mediated signaling | May 15, 2007 | Abandoned |
Array
(
[id] => 4779356
[patent_doc_number] => 20080287354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Prosaposin as a neurotrophic factor'
[patent_app_type] => utility
[patent_app_number] => 11/787486
[patent_app_country] => US
[patent_app_date] => 2007-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6331
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287354.pdf
[firstpage_image] =>[orig_patent_app_number] => 11787486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/787486 | Prosaposin as a neurotrophic factor | Apr 15, 2007 | Abandoned |
Array
(
[id] => 4915232
[patent_doc_number] => 20080095832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Prosaposin as a neurotrophic factor'
[patent_app_type] => utility
[patent_app_number] => 11/787565
[patent_app_country] => US
[patent_app_date] => 2007-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6333
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11787565
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/787565 | Prosaposin as a neurotrophic factor | Apr 15, 2007 | Abandoned |
Array
(
[id] => 5187982
[patent_doc_number] => 20070166290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Lineage Restricted Glial Precursors from the Central Nervous System'
[patent_app_type] => utility
[patent_app_number] => 11/694221
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11205
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166290.pdf
[firstpage_image] =>[orig_patent_app_number] => 11694221
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/694221 | Lineage restricted glial precursors from the central nervous system | Mar 29, 2007 | Issued |
Array
(
[id] => 8642631
[patent_doc_number] => 08367615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Stimulation of neuron regeneration by secretory leukocyte protease inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/225639
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14219
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12225639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225639 | Stimulation of neuron regeneration by secretory leukocyte protease inhibitor | Mar 29, 2007 | Issued |
Array
(
[id] => 6615741
[patent_doc_number] => 20100310570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MAPC TREATMENT OF BRAIN INJURIES AND DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/161830
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19376
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12161830
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161830 | MAPC treatment of brain injuries and diseases | Jan 22, 2007 | Issued |
Array
(
[id] => 6615741
[patent_doc_number] => 20100310570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MAPC TREATMENT OF BRAIN INJURIES AND DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/161830
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19376
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12161830
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161830 | MAPC treatment of brain injuries and diseases | Jan 22, 2007 | Issued |
Array
(
[id] => 4982821
[patent_doc_number] => 20070087379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'YS68 gene involved in primitive hematopoiesis'
[patent_app_type] => utility
[patent_app_number] => 11/643069
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16687
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20070087379.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643069
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643069 | YS68 gene involved in primitive hematopoiesis | Dec 19, 2006 | Issued |
Array
(
[id] => 5113747
[patent_doc_number] => 20070197663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Methods of treating memory and cognitive impairments in humans following stroke and traumatic brain injury'
[patent_app_type] => utility
[patent_app_number] => 11/636703
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 59955
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636703 | Methods of treating memory and cognitive impairments in humans following stroke and traumatic brain injury | Dec 7, 2006 | Abandoned |
Array
(
[id] => 8981843
[patent_doc_number] => 08512958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Methods of identifying agents that modulate mitochondrial function'
[patent_app_type] => utility
[patent_app_number] => 11/636110
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 19744
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11636110
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636110 | Methods of identifying agents that modulate mitochondrial function | Dec 6, 2006 | Issued |
Array
(
[id] => 4676851
[patent_doc_number] => 20080214482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Retromer-based assays and methods for treating alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/599896
[patent_app_country] => US
[patent_app_date] => 2006-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9668
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11599896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/599896 | Retromer-based assays and methods for treating alzheimer's disease | Nov 13, 2006 | Abandoned |
Array
(
[id] => 5125900
[patent_doc_number] => 20070238171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations'
[patent_app_type] => utility
[patent_app_number] => 11/590686
[patent_app_country] => US
[patent_app_date] => 2006-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13120
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238171.pdf
[firstpage_image] =>[orig_patent_app_number] => 11590686
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/590686 | Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations | Oct 30, 2006 | Abandoned |
Array
(
[id] => 4824798
[patent_doc_number] => 20080124276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Synthetic cornea from retinal stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/584412
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 49092
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11584412
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/584412 | Synthetic cornea from retinal stem cells | Oct 18, 2006 | Abandoned |
Array
(
[id] => 5034168
[patent_doc_number] => 20070098707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Methods and Compositions for Inhibiting C-MET Dimerization and Activation'
[patent_app_type] => utility
[patent_app_number] => 11/537751
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24058
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098707.pdf
[firstpage_image] =>[orig_patent_app_number] => 11537751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/537751 | Methods and Compositions for Inhibiting C-MET Dimerization and Activation | Oct 1, 2006 | Abandoned |
Array
(
[id] => 7691498
[patent_doc_number] => 20070232535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'GFRalpha3 and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/529680
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 33412
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232535.pdf
[firstpage_image] =>[orig_patent_app_number] => 11529680
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/529680 | GFRα3 polypeptides | Sep 26, 2006 | Issued |
Array
(
[id] => 5108979
[patent_doc_number] => 20070067857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Therapeutic agent for NGF'
[patent_app_type] => utility
[patent_app_number] => 11/519773
[patent_app_country] => US
[patent_app_date] => 2006-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11594
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20070067857.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519773
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519773 | Therapeutic agent for NGF | Sep 12, 2006 | Abandoned |
Array
(
[id] => 5108978
[patent_doc_number] => 20070067856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => ' Therapeutic agent for NGF'
[patent_app_type] => utility
[patent_app_number] => 11/519772
[patent_app_country] => US
[patent_app_date] => 2006-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11563
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20070067856.pdf
[firstpage_image] =>[orig_patent_app_number] => 11519772
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/519772 | Therapeutic agent for NGF | Sep 12, 2006 | Abandoned |
Array
(
[id] => 4771858
[patent_doc_number] => 20080057516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Novel receptor for GDNF family ligands'
[patent_app_type] => utility
[patent_app_number] => 11/512408
[patent_app_country] => US
[patent_app_date] => 2006-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13045
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057516.pdf
[firstpage_image] =>[orig_patent_app_number] => 11512408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/512408 | Receptor for GDNF family ligands | Aug 29, 2006 | Issued |
Array
(
[id] => 5532947
[patent_doc_number] => 20090232735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/064491
[patent_app_country] => US
[patent_app_date] => 2006-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 26686
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232735.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064491
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064491 | USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER | Aug 23, 2006 | Abandoned |
Array
(
[id] => 5688925
[patent_doc_number] => 20060287240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Method of stimulating prosaposin receptor activity'
[patent_app_type] => utility
[patent_app_number] => 11/508033
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3457
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287240.pdf
[firstpage_image] =>[orig_patent_app_number] => 11508033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/508033 | Method of stimulating prosaposin receptor activity | Aug 20, 2006 | Abandoned |